Antibiotic Based Articles & Analysis
13 news found
Compared with measuring the potency chemically, assessing antibiotic potency microbiologically can verify the ability of the antibiotic to destroy selected organisms and the concentrations at which the antibiotic can work effectively. ...
BySTEMart
The second product is a Levofloxacin SR Ocular Implant, an antibiotic-based ocular implant, being developed as a treatment to reduce the risk of infection after cataract surgery. PolyActiva is based in Melbourne, Australia, and has secured venture capital funding from Brandon Capital’s Medical Research Commercialisation Fund (MRCF) and ...
The company has recently announced the launch of PCR-based microbial antibiotic resistance gene analysis service to help researchers develop new antimicrobial medicines to address the worldwide threat of antibiotic resistance. ...
(NASDAQ: AQB) is a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. ...
(NASDAQ: AQB) is a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. ...
(NASDAQ: AQB) is a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. ...
About AquaBounty AquaBounty Technologies, Inc. is a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. ...
About AquaBounty AquaBounty Technologies, Inc. is a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. ...
About AquaBounty AquaBounty Technologies, Inc. is a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. ...
About AquaBounty AquaBounty Technologies, Inc. is a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. ...
The management of patients with bacterial infections relies on the early detection and identification of pathogens, as it enables the appropriate administration of antibiotics which saves lives. In the case of more serious conditions, such as sepsis, treatment should be started within an hour of the diagnosis. ...
SEATTLE (March 29, 2017) Newly published, peer-reviewed results of observational clinical research have demonstrated that ID Genomics’ “bacterial fingerprinting” technology has the potential to improve antibiotic prescribing, reducing prescription errors and the overuse of broad-spectrum antibiotics, which could ultimately improve patient ...
ID Genomics is developing innovative “bacterial fingerprinting” technology that has the potential to reduce prescription errors and the overuse of broad-spectrum antibiotics by improving the accuracy and speed of antibiotic prescribing process. ...